Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Intervacc

0.74 SEK

+0.27 %

Less than 1K followers

IVACC

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Intervacc

EV/S

Median 2019-2021

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)13.4539.3439.6419.375.431.000.92
Shares52.667.367.367.888.388.3340.8
Market cap708.12,646.52,668.51,312.8479.488.6314.9
Enterprise value655.52,482.32,552.8----
EV/S54.0519.3487.1----
EV/EBITDAneg.neg.neg.----
EV/EBITneg.neg.neg.----
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B3.227.848.665.252.010.551.15
P/S58.3553.7509.2135.659.87.515.7
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio92.7 %95.0 %93.6 %94.4 %91.6 %86.7 %93.4 %
Gearing ratio-------
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.